Monday, July 12, 2021Last Friday, markets put up an heroic effort to reverse big losses from the previous trading day and finish in the green for the full week. The S&P 500 even posted yet another record closing high by the final bell Friday. This is ahead of the unofficial start to Q2 earnings season, which begins this week with a higher level of major corporations announcing earnings results.These include, from a market cap perspective, some of the biggest companies on Wall Street: the Big Banks. On Tuesday morning, we expect results from JPMorgan JPM and Goldman Sachs GS. Wednesday brings us Bank of America BAC, Citigroup C and Wells Fargo WFC, while Morgan Stanley MS reports Thursday. Just examining results of these companies alone will give us a good sense of how Q2 earnings should unfold.In addition, PepsiCo PEP and ConAgra CAG report quarterly results Tuesday, Delta Air Lines DAL on Wednesday and UnitedHealth UNH Thursday. All in all, Q2 earnings growth rates are expected to climb 65% year over year — off an historically low base effect from Q2 a year ago, at the abyss of the pandemic economy, but also providing true earnings growth as the economy builds back to normal.Elsewhere, beginning tomorrow, we will also see a bevy of economic reports to help articulate the improvements made over the past three months, including CPI and PPI for June, Empire State and Philly Fed surveys for July, and, of course, weekly jobless claims. We’ll also see new Retail Sales, Import/Export numbers and Industrial Production/Capacity Utilization figures, all for June.Currently, we’re looking at mixed markets ahead of the first trading day of the new week, with positive sentiment tacking back toward (tech) growth names on the Nasdaq, +55 points, and away from the more value-based blue chips on the Dow, -130 points. The S&P 500 looks to split the difference at this hour, roughly flat 45 minutes before the market opens. We’re light on earnings and economic data today, but there’s always a chance for a change in market sentiment.Questions or comments about this article and/or its author? Click here>> Breakout Biotech Stocks with Triple-Digit Profit Potential The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases. Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.See these 7 breakthrough stocks now>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Goldman Sachs Group, Inc. (GS): Free Stock Analysis Report Bank of America Corporation (BAC): Free Stock Analysis Report Wells Fargo & Company (WFC): Free Stock Analysis Report JPMorgan Chase & Co. (JPM): Free Stock Analysis Report Morgan Stanley (MS): Free Stock Analysis Report Citigroup Inc. (C): Free Stock Analysis Report UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report Delta Air Lines, Inc. (DAL): Free Stock Analysis Report PepsiCo, Inc. (PEP): Free Stock Analysis Report CONAGRA BRANDS (CAG): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report